INS and neoplasm: Previous studies indicated that when insulin binds to its receptor, it initiates the sequence of phosphorylation events that lead to activation of the catalytic activity of phosphoinositide 3-kinase, and when chronically activated, this signal pathway can drive malignant transformation and tumor progression [17, 36, 37].